Skip to main content

AMERIPRISE FINANCIAL INC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 820027 MINNEAPOLIS, MN

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
183,578
-68.9% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 0% Shared 95% None 5%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 183,578
2025-12-31 589,597
2025-09-30 717,703
2025-06-30 750,161
2025-03-31 466,661
2024-12-31 882,801
2024-09-30 860,294
2024-06-30 783,914
2024-03-31 531,362
2023-12-31 565,580
2023-09-30 352,392
2023-06-30 141,078
2023-03-31 79,673
2022-12-31 57,640
2022-09-30 56,541
2022-06-30 178,704
2022-03-31 169,621
2021-12-31 166,688
2021-09-30 202,712
2021-06-30 134,157